Table 6 |
||||||||
|
Trials testing magnesium |
||||||||
|
Reference |
Study Design |
Sample Population |
Intervention |
Control |
Length of Treatment |
Outcomes |
Direction of Evidence |
Reported Adverse Events |
|
|
||||||||
|
Carroll (2000) [75] |
Randomized; Double-blind; Parallel Group |
80 healthy males |
Berocca: oral multivitamin1 |
Placebo |
28 days |
Multivitamin treatment significantly reduced anxiety as measured by GHQ-28, HADS and PSS. |
+ |
Not reported |
|
|
||||||||
|
De Souza (2000) [76] |
Randomized; Double-blind; Crossover (4) |
44 women with adverse premenstrual symptoms but otherwise in good health |
(1) 200 mg Mg, (2) 50 mg vitamin B6, (3) 200 mg Mg + 50 mg vitamin B6 per day |
Placebo |
One menstrual cycle |
200 mg/day Mg + 50 mg/day vitamin B6 significantly reduced anxiety-related premenstrual symptoms |
+ |
Participants were not specifically asked, but none were reported spontaneously |
|
|
||||||||
|
Hanus (2004) [77] |
Randomized; Double-blind; Parallel Group |
264 patients with generalized anxiety (DSM-III-R) of mild-to-moderate intensity2 |
Sympathyl: extracts of crataegus oxyacantha and eschscholtzia californica plus magnesium |
Placebo |
3 months |
Significant clinical improvement in anxiety3 in favour of the combination treatment |
+ |
No serious AEs related to treatment4 |
|
|
||||||||
|
GHQ-28: General Health Questionnaire; HADS: Hospital Anxiety and Depression Scale; PSS: Perceived Stress Scale; DMS-II-R: Diagnostic and Statistical Manual of Mental Disorders, third edition revised; HAMA: Hamilton Anxiety Scale; HAMA-SOM: Hamilton Anxiety Scale, subscore somatic anxiety; HAMA-T: Hamilton Anxiety Scale, total score (HAMA-T 1. Multivitamin containing vitamin B1 (15 mg), B2 (15 mg), niacin (50 mg), pantothenic acid (23 mg), B6 (10 mg), biotin (150 mcg), folic acid (400 mcg), B12 (10 mcg), C (500 mg), calcium (100 mg), magnesium (100 mg), zinc (10 mg). 2. Total HAMA score between 16 and 28. 3. Measured by HAMA-T and HAMA-SOM and subjective patient-rated anxiety. Headache, muscular stiffness, insomnia, drowsiness, indifference, anxiety, palpitations, nausea (4), gastralgia, diarrhea, gastric heaviness, dysuria, colic renal pain, morning sluggishness (3), asthenia. |
||||||||
|
Lakhan and Vieira Nutrition Journal 2010 9:42 doi:10.1186/1475-2891-9-42 |
||||||||